Mechanisms underlying cytotoxicity induced by engineered nanomaterials: A review of in vitro studies

Nanomaterials

Volumn 4, Issue 2, 2014, Pages 454-484

  Nogueira, Daniele R ^a   Mitjans, Montserrat ^b,c   Rolim, Clarice M B ^a   Vinardell, M Pilar ^b,c  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CSIC   (Spain)

Author keywords

Cell culture; Cytotoxicity; In vitro methods; Nanomaterials; Nanosafety

Indexed keywords

EID: 84994767778     PISSN: None     EISSN: 20794991     Source Type: Journal    
DOI: 10.3390/nano4020454     Document Type: Review

References (128)

1. Hartung, T. Food and thought…on alternative methods for nanoparticle safety testing. ALTEX 2010, 27, 87–95.
2. Horie, M.; Kato, H.; Fujita, K.; Endoh, S.; Iwahashi, H. In vitro evaluation of cellular response induced by manufactured nanoparticles. Chem. Res. Toxicol. 2012, 25, 605–619.
3. Paillard, A.; Hindré, F.; Vignes-Colombeix, C.; Benoit, J.-P.; Garcion, E. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials 2010, 31, 7542–7554.
4. Singh, R.; Lillard, J.W., Jr. Nanoparticle-based target drug delivery. Exp. Mol. Pathol. 2009, 86, 215–223.
5. Sahoo, S.K.; Parveen, S.; Panda, J.J. The present and future of nanotechnology in human health care. Nanomedicine 2007, 3, 20–31.
6. Parveen, S.; Sahoo, S.K. Polymeric nanoparticles for cancer therapy. J. Drug Target. 2008, 16, 108–123.
7. Nogueira, D.R.; Tavano, L.; Mitjans, M.; Pérez, L.; Infante, M.R.; Vinardell, M.P. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles. Biomaterials 2013, 34, 2758–2772.
8. Robbens, J.; Vanparys, C.; Nobels, I.; Blust, R.; Hoecke, K.V.; Janssen, C.; Schamphelaere, K.D.; Roland, K.; Blanchard, G.; Silvestre, F.; et al. Eco-, geno-, and human toxicology of bio-active nanoparticles for biomedical applications. Toxicology 2010, 269, 170–181.
9. Donaldson, K.; Stone, V.; Tran, C.L.; Kreyling, W.; Borm, P.J.A. Nanotoxicology. Occup. Environ. Med. 2004, 61, 727–728.
10. Chen, C.; Li, Y.F.; Qu, Y.; Chai, Z.; Zhao, Y. Advanced nuclear analytical and related techniques for the growing challenges in nanotoxicology. Chem. Soc. Rev. 2013, 42, 8266–8303.
11. Oberdörster, G.; Stone, V.; Donaldson, K. Toxicology of nanoparticles: A historical perspective. Nanotoxicology 2007, 1, 1–25.
12. Borm, P.J.A.; Robbins, D.; Haubold, S.; Kuhlbusch, T.; Fissan, H.; Donaldson, K.; Schins, R.; Stone, V.; Kreyling, W.; Lademann, J.; et al. The potential risks of nanomaterials: A review carried out for ECETOC. Part. Fibre Toxicol. 2006, 3, 11.
13. Savolainen, K.; Alenius, H.; Norppa, H.; Pylkkänen, L.; Tuomi, T.; Kasper, G. Risk assessment of engineered nanomaterials and nanotechnologies—A review. Toxicology 2010, 269, 92–104.
14. Winkler, D.A.; Mombelli, E.; Pietroiusti, A.; Tran, L.; Worth, A.; Fadeel, B.; McCall, M.J. Applying quantitative structure-activity relationship approaches to nanotoxicology: Current status and future potential. Toxicology 2013, 313, 15–23.
15. Boverhof, D.R.; David, R.M. Nanomaterial characterization: Considerations and needs for hazard assessment and safety evaluation. Anal. Bioanal. Chem. 2010, 396, 953–961.
16. REACH (Registration, Evaluation, Authorisation and Restriction of Chemical substances), Regulation (EC) No 1907/2006 of the European Parliament and of the Council, of 18 December 2006.
17. Clark, K.A.; White, R.H.; Silbergeld, E.K. Predictive models for nanotoxicology: Current challenges and future opportunities. Regulatory Toxicol. Pharmacol. 2011, 59, 361–363.
18. Ai, J.; Biazar, E.; Jafarpour, M.; Montazeri, M.; Majdi, A.; Aminifard, S.; Zafari, M.; Akbari, H.R.; Rad, H.G. Nanotoxicology and nanoparticle safety in biomedical designs. Int. J. Nanomed. 2011, 6, 1117–1127.
19. Yang, H.; Liu, C.; Yang, D.; Zhang, H.; Xi, Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: The role of particle size, shape and composition. J. Appl. Toxicol. 2009, 29, 69–78.
20. Nogueira, D.R.; Morán, M.C.; Mitjans, M.; Pérez, L.; Ramos, D.; de Lapuente, J.; Vinardell, M.P. Lysine-based surfactants in nanovesicle formulations: The role of cationic charge position and hydrophobicity in in vitro cytotoxicity and intracellular delivery. Nanotoxicology 2014, 8, 404–421.
21. Hillegass, J.M.; Shukla, A.; Lathrop, S.A.; MacPherson, M.B.; Fukagawa, N.K.; Mossman, B.T. Assessing toxicity in cells in vitro. WIREs Nanomed. Nanotechnol. 2009, 2, 219–231.
22. Jones, C.F.; Grainger, D.W. In vitro assessments of nanomaterial toxicity. Adv. Drug Deliv. Rev. 2009, 61, 438–456.
23. Oberdörster, G. Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J. Intern. Med. 2009, 267, 89–105.
24. Hartung, T. Food and thought…on cell culture. ALTEX 2007, 24, 143–147.
25. Monteiro-Riviere, N.A.; Inman, A.O.; Zhang, L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 2009, 234, 222–235.
26. Monteiro-Riviere, N.A.; Oldenburg, S.J.; Inman, A.O. Interactions of aluminum nanoparticles with human epidermal keratinocytes. J. Appl. Toxicol. 2010, 30, 276–285.
27. Hartung, T.; Leist, M. Food and thought…on the evolution of toxicology and phasing out of animal testing. ALTEX 2008, 25, 91–96.
28. Nyland, J.F.; Silbergeld, E.K. A nanobiological approach to nanotoxicology. Hum. Exp. Toxicol. 2009, 28, 393–400.
29. Oberdörster, G.; Maynard, A.; Donaldson, K.; Castranova, V.; Fitzpatrick, J.; Ausman, K.; Carter, J.; Karn, B.; Kreyling, W.; ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group; et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part. Fibre Toxicol. 2005, 2, 8.
30. Guzelian, P.S.; Victoroff, M.S.; Halmes, C.; James, R.C. Clear path: Towards an evidence-based toxicology (EBT). Hum. Exp. Toxicol. 2009, 28, 71–79.
31. Nogueira, D.R.; Morán, M.C.; Mitjans, M.; Martínez, V.; Pérez, L.; Vinardell, M.P. New cationic nanovesicular systems containing lysine-based surfactants for topical administration: Toxicity assessment using representative skin cell lines. Eur. J. Pharm. Biopharm. 2013, 83, 33–43.
32. Ucciferri, N.; Collnot, E.-M.; Gaiser, B.; Tirella, A.; Stone, V.; Domenici, C.; Lehr, C.-M.; Ahluwalia, A. In vitro toxicological screening of nanoparticles on primary human endothelial cells and the role of flow in modulating cell respose. Nanotoxicology 2014, 8, 697–708.
33. Coulter, J.A.; Jain, S.; Butterworth, K.T.; Taggart, L.E.; Dickson, G.R.; McMahon, S.J.; Hyland, W.B.; Muir, M.F.; Trainor, C.; Hounsell, A.R.; et al. Cell type-dependent uptake, localization,and cytotoxicity of 1.9 nm gold nanoparticles. Int. J. Nanomed. 2012, 7, 2673–2685.
34. Paul, A.; Das, S.; Das, J.; Samadder, A.; Khuda-Bukhsh, A.R. Cytotoxicity and apoptotic signalling cascade induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells in vitro and bioavailability of nano-chelidonine in mice in vivo. Toxicol. Lett. 2013, 222, 10–22.
35. Sambandam, B.; Palanisami, E.; Abbugounder, R.; Prakhya, B.; Thiyagarajan, D. Characterizations of coal fly ash nanoparticles and induced in vitro toxicity in cell lines. J. Nanopart. Res. 2014, 16, doi:10.1007/s11051-013-2217-x.
36. 2, CdO, CdS micro-and nanoparticles) in renal cells. Toxicol. Res. 2014, 3, 32–41.
37. 2) nanoparticles on human erythrocyte and lymphocyte cells in vitro. J. Appl. Toxicol. 2013, 33, 1097–1110.
38. Liao, K.-H.; Lin, Y.-S.; Macosko, C.W.; Haynes, C.L. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl. Mater. Interfaces 2011, 3, 2607–2615.
39. Berridge, M.V.; Herst, P.M.; Tan, A.S. Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction. Biotechnol. Annu. Rev. 2005, 11, 127–152.
40. Chueh, P.J.; Lianga, R.-Y.; Leea, Y.-H.; Zenga, Z.-M.; Chuanga, S.-M. Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines. J. Hazard. Mat. 2014, 264, 303–312.
41. Xia, T.; Kovochich, M.; Liong, M.; Zink, J.I.; Nel, A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2008, 2, 85–96.
42. Ojer, P.; Neutsch, L.; Gabor, F.; Irache, J.M.; de Cerain, A.L. Cytotoxicity and cell interaction studies of bioadhesivepoly(anhydride) nanoparticles for oral antigen/drug delivery. J. Biomed. Nanotechnol. 2013, 9, 1891–1903.
43. Vetten, M.A.; Tlotleng, N.; Rascher, D.T.; Skepu, A.; Keter, F.K.; Boodhia, K.; Koekemoer, L.A.; Andraos, C.; Tshikhudo, R.; Gulumian, M. Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines. Part. Fibre Toxicol. 2013, 10, 50.
44. Ha, S.-W.; Sikorski, J.A.; Weitzmann, M.N.; Beck, G.R., Jr. Bio-active engineered 50 nm silica nanoparticles with bone anabolic activity: Therapeutic index, effective concentration, and cytotoxicity profile in vitro. Toxicol. In Vitro 2014, 28, 354–364.
45. Foldbjerg, R.; Wang, J.; Beer, C.; Thorsen, K.; Sutherland, D.S.; Autrup, H. Biological effects induced by BSA-stabilized silica nanoparticles in mammalian cell lines. Chem. Biol. Interac. 2013, 204, 28–38.
46. Sun, X.; Wang, Z.; Zhai, S.; Cheng, Y.; Liu, J.; Liu, B. In vitro cytotoxicity of silver nanoparticles in primary rat hepatic stellate cells. Mol. Med. Rep. 2013, 8, 1365–1372.
47. Chuang, S.M.; Lee, Y.H.; Liang, R.Y.; Roam, G.D.; Zeng, Z.M.; Tu, H.F.; Wang, S.K.; Chueh, P.J. Extensive evaluations of the cytotoxic effects of gold nanoparticles. Biochim. Biophys. Acta 2013, 830, 4960–4973.
48. Nymark, P.; Catalán, J.; Suhonen, S.; Jarventaus, H.; Birkedal, R.; Clausen, P.A.; Jensen, K.A.; Vippola, M.; Savolainen, K.; Norppa, H. Genotoxicity of polyvinylpyrrolidone-coated silver nanoparticles in BEAS 2B cells. Toxicology 2013, 313, 38–48.
49. Karlsson, H.L.; Cronholm, P.; Hedberg, Y.; Tornberg, M.; de Battice, L.; Svedhem, S.; Wallinder, I.O. Cell membrane damage and protein interaction induced by copper containing nanoparticles—Importance of the metal release process. Toxicology 2013, 313, 59–69.
50. Hwang, T.-L.; Sung, C.T.; Aljuffali, I.A.; Chang, Y.-T.; Fang, J.-Y. Cationic surfactants in the form of nanoparticles and micelles elicit different human neutrophil responses: A toxicological study. Colloids Surf. B Biointerfaces 2014, 114, 334–341.
51. Haniu, H.; Saito, N.; Matsuda, Y.; Kim, Y.A.; Park, K.C.; Tsukahara, T.; Usui, Y.; Aoki, K.; Shimizu, M.; Ogihara, N.; et al. Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines. Int. J. Nanomed. 2011, 6, 3487–3497.
52. Darolles, C.; Sage, N.; Armengaud, J.; Malard, V. In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference. Toxicol. In Vitro 2013, 27, 1699–1710.
53. Sahu, S.C.; Zheng, J.; Graham, L.; Chen, L.; Ihried, J.; Yourick, J.J.; Sprando, R.L. Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. J. Appl. Toxicol. 2014, doi:10.1002/jat.2994.
54. Everett, W.N.; Chernb, C.; Suna, D.; McMahonb, R.E.; Zhanga, X.; Chenc, W.-J.A.; Hahn, M.S.; Sue, H.-J. Phosphate-enhanced cytotoxicity of zinc oxide nanoparticles andagglomerates. Toxicol. Lett. 2014, 225, 177– 184.
55. Demir, E.; Akça, H.; Kaya, B.; Burgucu, D.; Tokgün, O.; Turna, F.; Aksakal, S.; Vales, G.; Creus, A.; Marcos, R. Zinc oxide nanoparticles: Genotoxicity, interactions with UV-light and cell-transforming potential. J. Hazard Mater. 2014, 264, 420–429.
56. De Simone, U.; Manzo, L.; Profumo, A.; Coccini, T. In vitro toxicity evaluation of engineered cadmium-coated silica nanoparticles on human pulmonary cells. J. Toxicol. 2013, 2013, doi: 10.1155/2013/931785.
57. Prodan, A.M.; Iconaru, S.L.; Ciobanu, C.S.; Chifiriuc, M.C.; Stoicea, M.; Predoi, D. Iron oxide magnetic nanoparticles: Characterization and toxicity evaluation by in vitro and in vivo assays. J. Nanomater. 2013, 2013, 587021:1–587021:10.
58. Tran, T.B.; Nguyen, P.D.; Um, S.H.; Son, S.J.; Min, J. Real-time monitoring in vitro cellular cytotoxicity of silica nanotubes using electric cell-substrate impedance sensing (ECIS). J. Biomed. Nanotechnol. 2013, 9, 286–290.
59. Zimmer, C.C.; Liu, Y.X.; Morgan, J.T.; Yang, G.; Wang, K.H.; Kennedy, I.M.; Barakat, A.I.; Liu, G.Y. New approach to investigate the cytotoxicity of nanomaterials using single cell mechanics. J. Phys. Chem. B 2014, 118, 1246–1255.
60. Frohlich, E.; Meindl, C.; Roblegg, E.; Griesbacher, A.; Pieber, T.R. Cytotoxicity of nanoparticles is influenced by size, proliferation and embryogenic origin of the cells used for testing. Nanotoxicology 2012, 6, 424–439.
61. Nogueira, D.R.; Mitjans, M.; Infante, M.R.; Vinardell, M.P. Comparative sensitivity of tumor and non-tumor cell lines as a reliable approach for in vitro cytotoxicity screening of lysine-based surfactants with potential pharmaceutical applications. Int. J. Pharm. 2011, 420, 51–58.
62. Schroterová, L.; Králová, V.; Vorácová, A.; Hascová, P.; Rudorlf, E. Antiproliferative effects of selenium compounds in colon cancer cells: Comparison of different cytotoxicity assays. Toxicol. In Vitro 2009, 23, 1406–1411.
63. Guadagnini, R.; Halamoda Kenzaoui, B.; Cartwright, L.; Pojana, G.; Magdolenova, Z.; Bilanicova, D.; Saunders, M.; Juillerat, L.; Marcomini, A.; et al. Toxicity screenings of nanomaterials: Challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 2013, doi:10.3109/17435390.2013.829590.
64. Hashimoto, M.; Hirokazu, T.; Yonezawa, T.; Kawai, K.; Iijima, M.; Endo, K. Evaluation of Silver Nanoparticle toxicity to RAW264.7 cells in a three-dimensional cell culture. J. Biomater. Tissue Eng. 2014, 4, 51–58.
65. Sanchez, V.C.; Weston, P.; Yan, A.; Hurt, R.H.; Kane, A.B. A 3-dimensional in vitro model of epithelioidgranulomas induced by high aspect rationanomaterials. Part Fibre Toxicol. 2011, 8, doi:10.1186/1743-8977-8-17.
66. Gao, Y.; Li, M.; Chen, B.; Shen, Z.; Guo, P.; Wientjes, M.G.; Au, J.L. Predictive models of diffusive nanoparticle transport in 3-dimensional tumor cell spheroids. AAPS J. 2013, 15, 816–831.
67. El-Dakdouki, M.H.; Puré, E.; Huang, X. Development of drug loaded nanoparticles for tumor targeting. Part 2: Enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models. Nanoscale 2013, 5, 3904–3911.
68. Shi, W.-B.; Le, V.-M.; Gu, C.-H.; Zheng, Y.-H.; Lang, M.-D.; Lu, Y.-H.; Liu, J.-W. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles. J. Pharm. Sci. 2014, 103, 1064–1074.
69. Xu, X.; Sabanayagam, C.R.; Harrington, D.A.; Farach-Carson, M.C.; Jia, X. A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics. Biomaterials 2014, 35, 3319–3330.
70. Rocha, E.L.; Porto, L.M.; Rambo, C.R. Nanotechnology meets 3D in vitro models: Tissue engineered tumors and cancer therapies. Mater. Sci. Eng. C 2014, 34, 270–279.
71. Šinko, G.; Vrček, I.V.; Goessler, W.; Leitinger, G.; Dijanošić, A.; Miljanić, S. Alteration of cholinesterase activity as possible mechanism of silver nanoparticle toxicity. Environ. Sci. Pollut. Res. 2014, 21, 1391–1400.
72. Wang, Z.; Zhao, J.; Li, F.; Gao, D.; Xing, B. Adsorption and inhibition of acetylcholinesterase by different nanoparticles. Chemosphere 2009, 77, 67–73.
73. Wang, Z.; Zhang, K.; Zhao, J.; Liu, X.; Xing, B. Adsorption and inhibition of butyrylcholinesterase by different engineered nanoparticles. Chemosphere 2010, 79, 86–92.
74. Ellman, G.L.; Courtney, K.D.; Andres, V.; Feather-stone, R.M. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7, 88–95.
75. Deng, Z.J.; Butcher, N.J.; Mortimer, G.M.; Jia, Z.; Monteiro, M.J.; Martin, D.J.; Minchin, R.F. Interaction of human arylamine N-acetyltransferase 1 with different nanomaterials. Drug Metab. Dispos. 2014, 42, 377–383.
76. Käkinen, A.; Ding, F.; Chen, P.; Mortimer, M.; Kahru, A.; Ke, P.C. Interaction of firefly luciferase and silver nanoparticles and its impact on enzyme activity. Nanotechnology 2013, 24, 345101:1–345101:9.
77. Ciolkowski, M.; Rozanek, M.; Bryszewska, M.; Klajnert, B. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin. Biochim. Biophys. Acta 2013, 1834, 1982–1987.
78. Wang, Y.; Zhang, X.; Cheng, C.; Li, C. Mucoadhesive and enzymatic inhibitory nanoparticles for transnasal insulin delivery. Nanomedicine 2014, 9, 541–464.
79. Chairuangkitti, P.; Lawanprasert, S.; Roytrakul, S.; Aueviriyavit, S.; Phummiratch, D.; Kulthong, K.; Chanvorachote, P.; Maniratanachote, R. Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol. In Vitro 2013, 27, 330–338.
80. Khatri, M.; Bello, D.; Pal, A.K.; Cohen, J.M.; Woskie, S.; Gassert, T.; Lan, J.; Gu, A.Z.; Demokritou, P.; Gaines, P. Evaluation of cytotoxic, genotoxic and inflammatory responses of nanoparticles from photocopiers in three human cell lines. Part. Fibre Toxicol. 2013, 10, 42.
81. McCracken, C.; Zane, A.; Knight, D.A.; Dutta, P.K.; Waldman, W.J. Minimal intestinal epithelial cell toxicity in response to short-and long-term food-relevant inorganic nanoparticle exposure. Chem. Res. Toxicol. 2013, 26, 1514−1525.
82. Valodkar, M.; Jadeja, R.N.; Thounaojam, M.C.; Devkar, R.V.; Thakore, S. In vitro toxicity study of plant latex capped silver nanoparticles in human lung carcinoma cells. Mater. Sci. Eng. C 2011, 31, 1723–1728.
83. VanOs, R.; Lildhar, L.L.; Lehoux, E.A.; Beaulé, P.E.; Catelas, I. In vitro macrophage response to nanometer-size chromium oxide particles. J. Biomed. Mater. Res. B Appl. Biomater. 2014, 102, 149–159.
84. Yan, L.; Gu, Z.; Zhao, Y. Chemical mechanisms of the toxicological properties of nanomaterials: Generation of intracellular reactive oxygen species. Chem. Asian J. 2013, 8, 2342–2353.
85. Passagne, I.; Morille, M.; Rousset, M.; Pujalté, I.; L’azou, B. Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. Toxicology 2012, 299, 112–124.
86. LeBlanc, A.J.; Moseley, A.M.; Chen, B.T.; Frazer, D.; Castranova, V.; Nurkiewicz, T.R. Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism. Cardiovasc. Toxicol. 2010, 10, 27–36.
87. Shen, C.; James, S.A.; de Jonge, M.D.; Turney, T.W.; Wright, P.F.A.; Feltis, B.N. Relating cytotoxicity, zinc ions, and reactive oxygen in ZnO nanoparticle–exposed human immune cells. Toxicol. Sci. 2013, 136, 120–130.
88. Prasad, R.Y.; McGee, J.K.; Killius, M.G.; Suarez, D.A.; Blackman, C.F.; DeMarini, D.M.; Simmons, S.O. Investigating oxidative stress and inflammatory responses elicited by silver nanoparticles using high-throughput reporter genes in HepG2 cells: Effect of size, surface coating, and intracellular uptake. Toxicol. In Vitro 2013, 27, 2013–2021.
89. Akhtar, M.J.; Ahamed, M.; Kumar, S.; Siddiqui, H.; Patil, G.; Ashquin, M.; Ahmad, I. Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. Toxicology 2010, 276, 95–102.
90. Roy, R.; Parashar, V.; Chauhan, L.K.; Shanker, R.; Das, M.; Tripathi, A.; Dwivedi, P.D. Mechanism of uptake of ZnO nanoparticles and inflammatory responses in macrophages require PI3K mediated MAPKs signaling. Toxicol. In Vitro 2014, 28, 457–467.
91. Choi, A.O.; Cho, S.J.; Desbarats, J.; Lovric, J.; Maysinger, D. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J. Nanobiotechnol. 2007, 5, 1.
92. Tang, Y.; Wang, F.; Jin, C.; Liang, H.; Zhong, X.; Yang, Y. Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats. Environ. Toxicol. Pharmacol. 2013, 36, 66–72.
93. Baracca, A.; Sgarbi, G.; Solaini, G.; Lenaz, G. Rhodamine 123 as a probe of mitochondrial membrane potential: Evaluation of proton flux through F(0) during ATP synthesis. Biochim. Biophys. Acta 2003, 1606, 137–146.
94. Kang, S.J.; Lee, Y.J.; Kim, B.M.; Choi, Y.J.; Chung, H.W. Cytotoxicity and genotoxicity of titanium dioxide nanoparticles in UVA-irradiated normal peripheral blood lymphocytes. Drug Chem. Toxicol. 2011, 34, 277–284.
95. Sohaebuddin, S.; Thevenot, P.T.; Baker, D.; Eaton, J.W.; Tang, L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part. Fibre Toxicol. 2010, 7, 22.
96. Fröhlich, E.; Meindl, C.; Roblegg, E.; Ebner, B.; Absenger, M.; Pieber, T.R. Action of polystyrene nanoparticles of different sizes on lysosomal function and integrity. Part. Fibre Toxicol. 2012, 9, 26.
97. Lindberg, H.K.; Falck, G.C.; Singh, R.; Suhonen, S.; Järventaus, H.; Vanhala, E.; Catalán, J.; Farmer, P.B.; Savolainen, K.M.; Norppa, H. Genotoxicity of short single-wall and multi-wall carbon nanotubes in human bronchial epithelial and mesothelial cells in vitro. Toxicology 2013, 313, 24–37.
98. Shahbazi, M.A.; Hamidi, M.; Mäkilä, E.M.; Zhang, H.; Almeida, P.V.; Kaasalainen, M.; Salonen, J.J.; Hirvonen, J.T.; Santos, H.A. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. Biomaterials 2013, 34, 7776–7789.
99. Hsiao, I.-L.; Huang, Y.-J. Effects of serum on cytotoxicity of nano-and micro-sized ZnO particles. J. Nanopart. Res. 2013, 15, 1829.
100. Elsabahy, M.; Li, A.; Zhang, F.; Sultan, D.; Liu, Y.; Wooley, K.L. Differential immunotoxicities of poly(ethylene glycol)-vs. poly(carboxybetaine)-coated nanoparticles. J. Control. Release 2013, 172, 641–652.
101. Ricklin, D.; Hajishengallis, G.; Yang, K.; Lambris, J.D. Complement: A key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11, 785.
102. Pham, C.T.N.; Thomas, D.G.; Beiser, J.; Mitchell, L.M.; Huang, J.L.; Senpan, A.; Hu, G.; Gordon, M.; Baker, N.A.; Pan, D.; et al. Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2013, doi:10.1016/j.nano.2013.10.012.
103. Zarrabi, A.; Shokrgozar, M.A.; Vossoughi, M.; Farokhi, M. In vitro biocompatibility evaluations of hyperbranched polyglycerol hybrid nanostructure as a candidate for nanomedicine applications. J. Mater. Sci. Mater. Med. 2014, 25, 499–506.
104. Holl, M.M.B. Nanotoxicology: A personal perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1, 353–359.
105. Gaumet, M.; Vargas, A.; Gurny, R.; Delie, F. Nanoparticles for drug delivery: The need for precision in reporting particlesize parameters. Eur. J. Pharm. Biopharm. 2008, 69, 1–9.
106. Izak-Nau, E.; Voetz, M.; Eiden, S.; Duschl, A.; Puntes, V.F. Altered characteristics of silica nanoparticles in bovine and human serum: The importance of nanomaterial characterization prior to its toxicological evaluation. Part. Fibre Toxicol. 2013, 10, 56.
107. Kroll, A.; Pillukat, M.H.; Hahn, D.; Schnekenburger, J. Current in vitro methods in nanoparticle risk assessment: Limitations and challenges. Eur. J. Pharm. Biopharm. 2009, 72, 370–377.
108. 2 technique. Eur. J. Pharm. Biopharm. 2008, 70, 85–97.
109. 4-carbon composites for lithium-ion batteries. Nanomaterials 2013, 3, 443–452.
110. How, C.W.; Rasedee, A.; Manickam, S.; Rosli, R. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: Characterization, stability assessment and cytotoxicity. Colloids Surf. B Biointerfaces 2013, 112, 393–399.
111. Abdel-Mohsen, A.M.; Abdel-Rahman, R.M.; Fouda, M.M.G.; Vojtova, L.; Uhrova, L.; Hassan, A.F.; Al-Deyab, S.S.; El-Shamy, I.E.; Jancar, J. Preparation, characterization and cytotoxicity of schizophyllan/silver nanoparticle composite. Carbohydr. Polym. 2014, 102, 238–245.
112. Helfrich, A.; Bruchert, W.; Bettmer, J. Size characterization of Au nanoparticles by ICP-MS coupling techniques. J. Anal. At. Spectrom. 2006, 21, 431–434.
113. Yu, X.; Fan, H.; Liu, Y.; Shi, Z.; Jin, Z. Characterization of carbonized polydopamine nanoparticles suggests ordered supramolecular structure of polydopamine. Langmuir 2014, 30, 5497–5505.
114. Anuratha, M.; Jawahar, A.; Umadevi, M.; Sathe, V.G.; Vanelle, P.; Terme, T.; Meenakumari, V.; Benial, A.M.F. Orientation of N-(1-(2-chlorophenyl)-2-(2-nitrophenyl)ethyl)-4-methylbenzenesulfonamide on silver nanoparticles: SERS studies. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2014, 131C, 261–267.
115. Shi, J.; Hedberg, Y.; Lundin, M.; Wallinder, I.O.; Karlsson, H.L.; Möller, L. Hemolytic properties of synthetic nano-and porous silica particles: The effect of surface properties and the protection by the plasma corona. Acta Biomater. 2012, 8, 3478–3490.
116. Kuehl, C.; El-Gendy, N.; Berkland, C. NanoClusters surface area allows nanoparticle dissolution with microparticle properties. J. Pharm. Sci. 2014, 103, 1787–1798.
117. Nagaraja, A.T.; Pradhan, S.; McShane, M.J. Poly (vinylsulfonic acid) assisted synthesis of aqueous solution stable vaterite calcium carbonate nanoparticles. J. Colloid Interface Sci. 2014, 418, 366–372.
118. Rejman, J.; Oberle, V.; Zuhorn, I.S.; Hoekstra, D. Size-dependent internalization of particles via the pathways of chathrin-and caveolae-mediated endocytosis. Biochem. J. 2004, 377, 159–169.
119. Tavano, L.; Muzzalupo, R.; Mauro, L.; Pellegrino, M.; Andò, S.; Picci, N. Transferrin-conjugated pluronic niosomes as a new drug delivery system for anticancer therapy. Langmuir 2013, 29, 12638–12646.
120. Liu, D.; Chen, Y.; Feng, X.; Deng, M.; Xie, G.; Wang, J.; Zhang, L.; Liu, Q.; Yuan, P. Micellar nanoparticles loaded with gemcitabine and doxorubicin showed synergistic effect. Colloids Surf. B Biointerfaces, 2014, 113, 158–168.
121. Al Faraj, A.; Shaik, A.S.; Afzal, S.; Al Sayed, B.; Halwani, R. MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles. Int. J. Nanomedicine 2014, 9, 1491–1503.
122. Min, Y.; Li, J.; Liu, F.; Padmanabhan, P.; Yeow, E.K.L.; Xing, B. Recent advance of biological molecular imaging based on lanthanide-doped upconversion-luminescent nanomaterials. Nanomaterials 2014, 4, 129–154.
123. Tavano, L.; Vivacqua, M.; Carito, V.; Muzzalupo, R.; Caroleo, M.C.; Nicoletta, F. Doxorubicin loaded magneto-niosomes for targeted drug delivery. Colloids Surf. B Biointerfaces 2013, 102, 803–807.
124. Morán, M.C.; Nogueira, D.R.; Vinardell, M.P.; Miguel, M.G.; Lindman, B. Mixed protein-DNA gel particles for DNA delivery: Role of protein composition and preparation method on biocompatibility. Int. J. Pharm. 2013, 454, 192–203.
125. Wang, X.; Zhen, X.; Wang, J.; Zhang, J.; Wu, W.; Jiang, X. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles. Biomaterials 2013, 34, 4667–4679.
126. Lv, S.; Li, M.; Tang, Z.; Song, W.; Sun, H.; Liu, H.; Chen, X. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Acta Biomater. 2013, 9, 9330–9342.
127. Pollock, S.; Antrobus, R.; Newton, L.; Kampa, B.; Rossa, J.; Latham, S.; Nichita, N.B.; Dwek, R.A.; Zitzmann, N. Uptake and trafficking of liposomes to the endoplasmic reticulum. FASEB J. 2010, 24, 1866–1878.
128. Ng, C.-T.; Li, J.J.; Gurung, R.L.; Hande, M.P.; Ong, C.-N.; Bay, B.-H.; Yung, L.-Y.L. Toxicological profile of small airway epithelial cells exposed to gold nanoparticles. Exp. Biol. Med. 2013, 238, 1355–1361.